Radioimmunoscintigraphy of ovarian cancer with the MOv18 monoclonal antibody
Authors:
- G.L. BuraggiGBG.L. Buraggi
- E. Di ReERE. Di Re
- M. GaspariniMGM. Gasparini
- E. SeregniESE. Seregni
- S. CanevariSCS. Canevari
- M. GadinaMGM. Gadina
- M. PrestiMPM. Presti
- A. MariniAMA. Marini
- E. SeccamaniESE. Seccamani
- 1 June 1991
- journal article
- Published by Elsevier in European Journal of Cancer and Clinical Oncology
- Vol. 27 (6) , 724-729
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Preclinical pharmacokinetics and localization studies of the radioiodinated anti-ovarian carcinoma MAb MOv18International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, 1991
- A prospective imaging study of 131I-B72.3 monoclonal antibody in patients with epithelial ovarian cancerNuclear Medicine Communications, 1988
- Biodistribution, pharmacokinetics and imaging of131I-labelled OC125 in ovarian cancerInternational Journal of Cancer, 1988
- Characterization of human ovarian carcinoma‐associated antigens defined by novel monoclonal antibodies with tumor‐restricted specificityInternational Journal of Cancer, 1987
- Early results of the monoclonal antibody OVTL3 in specific detection of ovarian cancer.Journal of Clinical Oncology, 1987
- A prospective study of 123I-labeled monoclonal antibody imaging in ovarian cancer.Journal of Clinical Oncology, 1986
- Radionuclide imaging of ovarian tumours with a radiolabelled (123I) monoclonal antibody (NDOG2)European Journal of Nuclear Medicine and Molecular Imaging, 1985
- 123I radioiodinated antibody imaging of occult ovarian cancerCancer, 1985
- Common Epithelial Cancer of the OvaryNew England Journal of Medicine, 1985
- Common Epithelial Cancer of the OvaryNew England Journal of Medicine, 1985